CCL2 and metabolic dysfunction-associated steatohepatitis: Previous work by others demonstrated that deficiency of CCL2, a chemokine ligand of CCR2, did not prevent hepatitis in a methionine-choline deficient (MCD) mouse model of NASH [27].